$RGBP Very solid news update today. On top of the Hemaxellerate submission to the FDA, we now have dCellVax in the hands of the FDA as well. It has seemed to me that there has been a strategic release of all of the info disclosed in recent PR's; and that being of no surprise given Koos's background in sociology; all this meaning it appears they are setting the table. They may already have multiple offers on the table all awaiting the provision of FDA approval. There may also be a few pharma company's trying to take over, take down, or, legally acquire the disruptive intellectual properties here that have potential to cause negative growth within the portfolios of the pharma companies currently profiting off of yesteryear's technology. This is not the cut, burn, poison approach that is raking in the big bucks with cure rates that seem marginal, at best. We are witnessing a revolution in medicine thanks to the field of epigenomics and bioinformatics. Medicine is shifting from treating cancer as a symptom masquerading as an unidentified multi-mutational disease to a pattern of expression, which if silenced at the corresponding epigenetic marker(s), can be down-regulated or switched off entirely; best part being, science is now using these therapies to tutor missteps in the body's natural intelligence in such a way that the immune system raises its own iq in such a way that it can now provide for itself. I am very excited to see how all of this pans out.
Here are a few links that will lend credence to the solid info recently provided by the company:
Hemaxellerate GLP Results(in order of relevance):
http://www.prnewswire.com/news-releases/regen...10855.html
http://www.prnewswire.com/news-releases/regen...94211.html
Hiring of new President, Harry Lander:
http://www.prnewswire.com/news-releases/regen...12912.html
Harry Lander's Background:
http://weill.cornell.edu/mtnews/wcmcnews/Dr.%...ation.html
http://0380e28.netsolhost.com/sidra/team-memb...ry-lander/
Today's News Featuring dCellVax update:
http://www.kcentv.com/story/30499859/regen-bi...yne-cancer
John Wayne Cancer Institute:
http://california.providence.org/john-wayne/
UC San Diego University of Medicine; Santosh Kesari Laboratory, Department of Neurosciences:
http://kesarilab.ucsd.edu/Pages/default.aspx
Things appear to be lining up very favorably here. My opinion is that we will see at least one FDA approval some time soon. I hope to be right - for the company, the good of healthcare, and for all invested. Holding RGBP/BMSN long.
Here are a few links that will lend credence to the solid info recently provided by the company:
Hemaxellerate GLP Results(in order of relevance):
http://www.prnewswire.com/news-releases/regen...10855.html
http://www.prnewswire.com/news-releases/regen...94211.html
Hiring of new President, Harry Lander:
http://www.prnewswire.com/news-releases/regen...12912.html
Harry Lander's Background:
http://weill.cornell.edu/mtnews/wcmcnews/Dr.%...ation.html
http://0380e28.netsolhost.com/sidra/team-memb...ry-lander/
Today's News Featuring dCellVax update:
http://www.kcentv.com/story/30499859/regen-bi...yne-cancer
John Wayne Cancer Institute:
http://california.providence.org/john-wayne/
UC San Diego University of Medicine; Santosh Kesari Laboratory, Department of Neurosciences:
http://kesarilab.ucsd.edu/Pages/default.aspx
Things appear to be lining up very favorably here. My opinion is that we will see at least one FDA approval some time soon. I hope to be right - for the company, the good of healthcare, and for all invested. Holding RGBP/BMSN long.
Regen BioPharma Inc (RGBPD) Stock Research Links
Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
